974 results on '"Lesnick, Timothy G."'
Search Results
2. Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study
3. Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium
4. Complex relationships of socioeconomic status with vascular and Alzheimer’s pathways on cognition
5. Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
6. Tracking white matter degeneration in asymptomatic and symptomatic MAPT mutation carriers
7. Blood pressure changes impact corticospinal integrity and downstream gait and balance control
8. Association of plasma biomarkers of amyloid and neurodegeneration with cerebrovascular disease and Alzheimer's disease
9. Imaging biomarkers for early multiple system atrophy
10. Tau polygenic risk scoring: a cost-effective aid for prognostic counseling in Alzheimer’s disease
11. Associations of blood pressure with white matter hyperintensities later in life; influence of short-term menopausal hormone therapy.
12. Visual assessments of 11C-Pittsburgh compound-B PET vs. 18F-flutemetamol PET across the age spectrum.
13. 1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults
14. Rates of lobar atrophy in asymptomatic MAPT mutation carriers.
15. Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities
16. Cross-sectional Associations of β-Amyloid, Tau, and Cerebrovascular Biomarkers With Neurodegeneration in Probable Dementia With Lewy Bodies
17. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
18. Cerebrovascular disease, neurodegeneration, and clinical phenotype in dementia with Lewy bodies
19. The value of multimodal imaging with 123I-FP-CIT SPECT in differential diagnosis of dementia with Lewy bodies and Alzheimer's disease dementia
20. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
21. White Matter Abnormalities Track Disease Progression in Multiple System Atrophy.
22. Can integration of Alzheimer's plasma biomarkers with MRI, cardiovascular, genetics, and lifestyle measures improve cognition prediction?
23. Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCI
24. Complex Relationships of Socieconomic Status with Vascular and Alzheimer's Pathways on Cognition
25. NODDI in gray matter is a sensitive marker of aging and early AD changes.
26. Rates of lobar atrophy in asymptomatic MAPT mutation carriers
27. Cerebral Amyloid Angiopathy Pathology and Its Association With Amyloid-β PET Signal
28. NODDI May Be More Sensitive to Neurodegenerative Changes Than Structural MRI
29. Visual versus quantitative assessments using Pittsburgh compound‐B and Flutemetamol PET scans across age groups
30. Trajectories of plasma biomarkers of Alzheimer’s disease and neurodegeneration in the general population
31. Neurite-based white matter alterations in MAPT mutation carriers: A multi-shell diffusion MRI study in the ALLFTD consortium
32. Plasma biomarkers of Alzheimer´s disease in the continuum of dementia with Lewy bodies
33. Alzheimer’s disease biomarkers of amyloid and tau influence white matter neurite alterations in dementia with Lewy bodies: a NODDI study
34. A Machine Learning Approach to Identify Individualized Baseline MRI, Plasma, Cardiovascular and Lifestyle Predictors of a 5‐Year Cognitive Decline
35. Neurite‐based white matter alterations in MAPT mutation carriers: A multi‐shell diffusion MRI study in the ALLFTD consortium
36. Non‐imaging measures to predict variability in white matter changes relevant to VCID
37. Higher systolic and diastolic blood pressures in recently postmenopausal women are associated with greater WMH more than a decade later in the KEEPS Continuation
38. White matter changes with cerebrovascular disease and Alzheimer’s disease pathologies
39. Cardiometabolic outcomes in Kronos Early Estrogen Prevention Study continuation: 14-year follow-up of a hormone therapy trial
40. Boston criteria v2.0 for cerebral amyloid angiopathy without hemorrhage: An MRI-neuropathological validation study
41. Vascular risk, gait, behavioral, and plasma indicators of VCID
42. Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study
43. Mild Cognitive Impairment at Risk for Lewy Body Dementia
44. MRI and pathology of REM sleep behavior disorder in dementia with Lewy bodies
45. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers
46. Shapes of the Trajectories of 5 Major Biomarkers of Alzheimer Disease
47. Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
48. Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study
49. Neurofilament Light Chain in Spinal Fluid and Plasma in Multiple System Atrophy – A Prospective, Longitudinal Biomarker Study
50. An investigation of cerebrovascular lesions in dementia with Lewy bodies compared to Alzheimer's disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.